5
Participants
Start Date
May 6, 2021
Primary Completion Date
April 24, 2023
Study Completion Date
April 24, 2023
Regadenoson
Regadenoson will be given intravenously as 5 ug/kg (up to 400 mg/patient) loading dose over 30 mins (to avoid unpleasant side effects sometimes associated with the rapid bolus injection of Regadenoson), followed by a continuous slow infusion (1.44micrograms/kg/hour) with the use of a pediatric infusion pump for 6 hours.
Placebo Control
The same volume of saline will be given intravenously for 6 and half hours.
University of Maryland Medical Center, Baltimore
University of Maryland, Baltimore
OTHER